Vicks Inhaler

1. Name Of The Medicinal Product

Vicks Inhaler

2. Qualitative And Quantitative Composition

ACTIVE INGREDIENTS

	mg/inhaler	Specification
Menthol	125.00	EP
Camphor	50.00	EP
Siberian Pine Needle Oil	10.00	FP

3. Pharmaceutical Form

Nasal stick; for nasal use.

4. Clinical Particulars

4.1 Therapeutic Indications

The relief of nasal congestion associated with allergic and infectious upper respiratory tract disorders.

4.2 Posology And Method Of Administration

Adults and children over 6 years:	Vicks Inhaler is used by inserting the inhaler into each nostril, holding the other nostril closed and inhaling deeply.
It can be used as frequently as needed.
Children under 6 years:	Not recommended.

4.3 Contraindications

Use in patients hypersensitive to any of the ingredients.

4.4 Special Warnings And Precautions For Use

If symptoms persist consult your doctor.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

None.

4.6 Pregnancy And Lactation

None.

4.7 Effects On Ability To Drive And Use Machines

None.

4.8 Undesirable Effects

None.

4.9 Overdose

 4.9.1  Symptoms

None.

 4.9.2  Treatment of overdose

None.

5. Pharmacological Properties

5.1 Pharmacodynamic Properties

Menthol, Camphor and Siberian Pine Needle Oil act locally in the respiratory tract.

5.2 Pharmacokinetic Properties

The product exerts its action locally; little or no absorption is expected to occur.

5.3 Preclinical Safety Data

Not applicable.

6. Pharmaceutical Particulars

6.1 List Of Excipients

Methyl salicylate

6.2 Incompatibilities

None.

6.3 Shelf Life

36 months.

6.4 Special Precautions For Storage

Do not store above 25°C

6.5 Nature And Contents Of Container

A cellulose wick soaked in medication enclosed in a plastic holder with a plastic wick.

6.6 Special Precautions For Disposal And Other Handling

None.

7. Marketing Authorisation Holder

Procter & Gamble (Health & Beauty Care) Limited,

The Heights,

Brooklands,

Weybridge,

Surrey,

KT13 0XP,

UK.

8. Marketing Authorisation Number(S)

PL 0129/5009R

9. Date Of First Authorisation/Renewal Of The Authorisation

26th July 1994

10. Date Of Revision Of The Text

6^th August 1999